title: Expression in brain of amyloid precursor protein mutated in the alpha-secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice.
abstract: A double mutation in the alpha-secretase site in the betaA4 region of mouse amyloid precursor protein (APP) reduced its secretion from COS cells, polarized MDCK cells and rat primary neurons. Expression of this mutant in the brain of mice, using the neuron-specific elements of the mouse Thy-1 gene promoter, resulted in transgenic mice that became progressively hyperactive, displayed seizures and died prematurely. In three different transgenic lines the severity of the phenotype was related directly to the expression levels of the transgene, estimated by both mRNA and protein levels. In addition, homozygous mice derived from each transgenic strain showed more severe symptoms which also occurred earlier in life than in heterozygotes. The observed symptoms were, however, not essentially different in the different lines. Increased aggressiveness, disturbed responses to kainic acid and N-methyl-D-aspartate, neophobia and deficiency in exploratory behavior were demonstrated in these mice. In the brain, the observed neuropathological changes included necrosis, apoptosis and astrogliosis in the hippocampus, cortex and other areas. The data demonstrate that incomplete or incorrect alpha-secretase processing of APP results in severe neurotoxicity and that this effect is expressed in a dominant manner.
authors.affiliation: Experimental Genetics Group, Center for Human Genetics, Leuven, Belgium.
authors.forename: D
authors.initials: D
authors.lastname: Moechars
authors.forename: K
authors.initials: K
authors.lastname: Lorent
authors.forename: B
authors.initials: B
authors.lastname: De Strooper
authors.forename: I
authors.initials: I
authors.lastname: Dewachter
authors.forename: F
authors.initials: F
authors.lastname: Van Leuven
mesh_terms: D053829:Amyloid Precursor Protein Secretases; D016564:Amyloid beta-Protein Precursor / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D016282:Aspartic Acid Endopeptidases; D001522:Behavior, Animal; D001921:Brain / Q000187:drug effects / Q000473:pathology; D001928:Brain Diseases, Metabolic / Q000235:genetics / Q000401:mortality / Q000473:pathology / Q000523:psychology*; D010450:Endopeptidases / Q000378:metabolism*; D018690:Excitatory Amino Acid Agonists / Q000494:pharmacology; D006948:Hyperkinesis; D007608:Kainic Acid / Q000494:pharmacology; D051379:Mice; D008822:Mice, Transgenic; D009154:Mutation; D016202:N-Methylaspartate / Q000494:pharmacology; D009474:Neurons / Q000187:drug effects / Q000473:pathology; D011499:Protein Processing, Post-Translational; D012640:Seizures
chemical_list: D016564:Amyloid beta-Protein Precursor; D018690:Excitatory Amino Acid Agonists; D016202:N-Methylaspartate; D053829:Amyloid Precursor Protein Secretases; D010450:Endopeptidases; D016282:Aspartic Acid Endopeptidases; C509282:Bace1 protein, mouse; D007608:Kainic Acid